PRAX FY 2021 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$167M

Net Income

-$167M

EPS (Diluted)

$-58.96

Cash Flow

Operating Cash Flow

-$125M

Free Cash Flow

-$126M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$293M

Total Liabilities

$42M

Stockholders' Equity

$251M

Cash & Equivalents

$139M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$167M	-$62M	-170.0%
Net Income	-$167M	-$62M	-170.2%